Postoperative medicine for chondroblastoma
A cell tumor, cartilage-forming technology, applied in anti-tumor drugs, medical preparations containing active ingredients, bone diseases, etc., to increase the burden on the liver and kidney, reduce the type and dosage of drugs
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- Publication Date
- 2013-06-19
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The invention relates to the field of medicine for orthopedics, in particular to a medicine for postoperative chondroblastoma. Background technique
[0002] Chondroblastoma (benign chondroblastoma) is a common cartilaginous neoplasm of the epiphysis that develops before termination of endochondral bone formation. Most of them occur in the center of the epiphysis of long bones, especially in the major trochanters and the greater tuberosity of the epiphysis other than the end epiphysis. Long bones such as the upper and lower ends of the femur and the upper and lower ends of the tibia are the predilection sites, and the incidence near the knee joint accounts for almost half of the total number of tumors. Codman's tumor was also called Codman's tumor because it was first reported by Codman on the upper end of the humerus.
[0003] The treatment of benign chondroblastoma is based on bone grafting after complete curettage of tumor tissue. The postoperati...
Examples
Embodiment 1
Embodiment 2
Embodiment 3